Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123 Administered Orally to Healthy Adults.
Phase of Trial: Phase I
Latest Information Update: 07 Oct 2014
At a glance
- Drugs CRS 3123 (Primary)
- Indications Clostridium infections
- Focus Adverse reactions
- 02 Oct 2014 Status changed from recruiting to completed, as per ClinicalTrials.gov record.
- 01 May 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 26 Apr 2012 Planned End Date changed from 1 Dec 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.